APA
Haskell-Luevano C., Xiang Z., Wilczynski A. M., Haskell K. R., Andreasen A. M., Litherland S. A., Millard W. J., Pogozheva I. D., Mosberg H. I. & Sorenson N. B. (20090604). Discovery of a ligand that compensates for decreased endogenous agonist potency of melanocortin-4 receptor polymorphisms identified in obese humans. : Advances in experimental medicine and biology.
Chicago
Haskell-Luevano Carrie, Xiang Zhimin, Wilczynski Andrzej M, Haskell Kimberly R, Andreasen Amy M, Litherland Sally A, Millard William J, Pogozheva Ira D, Mosberg Henry I and Sorenson Nicholas B. 20090604. Discovery of a ligand that compensates for decreased endogenous agonist potency of melanocortin-4 receptor polymorphisms identified in obese humans. : Advances in experimental medicine and biology.
Harvard
Haskell-Luevano C., Xiang Z., Wilczynski A. M., Haskell K. R., Andreasen A. M., Litherland S. A., Millard W. J., Pogozheva I. D., Mosberg H. I. and Sorenson N. B. (20090604). Discovery of a ligand that compensates for decreased endogenous agonist potency of melanocortin-4 receptor polymorphisms identified in obese humans. : Advances in experimental medicine and biology.
MLA
Haskell-Luevano Carrie, Xiang Zhimin, Wilczynski Andrzej M, Haskell Kimberly R, Andreasen Amy M, Litherland Sally A, Millard William J, Pogozheva Ira D, Mosberg Henry I and Sorenson Nicholas B. Discovery of a ligand that compensates for decreased endogenous agonist potency of melanocortin-4 receptor polymorphisms identified in obese humans. : Advances in experimental medicine and biology. 20090604.